Search Results - "Nair, Sumithra"

Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts by Mehta‐Shah, Neha, Lunning, Matthew A., Moskowitz, Alison J., Boruchov, Adam M., Ruan, Jia, Lynch, Peggy, Hamlin, Paul A., Leonard, John, Matasar, Matthew J., Myskowski, Patricia L., Marzouk, Evan, Nair, Sumithra, Sholklapper, Tamir, Minnal, Veena, Palomba, Maria L., Vredenburgh, James, Kumar, Anita, Noy, Ariela, Straus, David J., Zelenetz, Andrew D., Schoder, Heiko, Rademaker, Jurgen, Schaffer, Wendy, Galasso, Natasha, Ganesan, Nivetha, Horwitz, Steven M.

“…Romidepsin (histone deacetylase inhibitor), lenalidomide (immunomodulatory agent), and carfilzomib (proteasome inhibitor), have efficacy and lack cumulative…”
Get full text

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma by Mehta-Shah, Neha, Lunning, Matthew Alexander, Boruchov, Adam M., Ruan, Jia, Nair, Sumithra, Lynch, Peggy, Byrne, Regina, Moskowitz, Alison J., Matasar, Matthew J., Gerecitano, John F., Hamlin, Paul A., Leonard, John, Moskowitz, Craig H., Myskowski, Patricia L., Querfeld, Christiane, Nolan, Patrick, Palomba, Maria Lia, Straus, David J., Zelenetz, Andrew David, Horwitz, Steven M.

“…Abstract only…”
Get full text

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results by Lunning, Matthew Alexander, Ruan, Jia, Nair, Sumithra, Boruchov, Adam M., Byrne, Regina, Gerecitano, John F., Hamlin, Paul A., Inserra, Beth, Leonard, John, Lynch, Peggy, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig, Myskowski, Patricia L., Nolan, Patrick, Palomba, Maria Lia, Quefeld, Christiane, Straus, David J., Zelenetz, Andrew David, Horwitz, Steven M.

“…Abstract only…”
Get full text